key: cord-0994193-1s940d7o
authors: Killen, Alison; Olsen, Kirsty; McKeith, Ian G.; Thomas, Alan J.; O'Brien, John T.; Donaghy, Paul; Taylor, John‐Paul
title: The challenges of COVID‐19 for people with dementia with Lewy bodies and family caregivers
date: 2020-08-18
journal: Int J Geriatr Psychiatry
DOI: 10.1002/gps.5393
sha: ae9900ea64f59561db0700c7c585e28b418df8c2
doc_id: 994193
cord_uid: 1s940d7o

nan

During the current SARS-CoV-2 pandemic dementia has been identified as disproportionally common in adults aged over 65 who develop severe COVID-19. 1 Observational data from the International Severe Acute Respiratory and Emerging Infections Consortium also confirms a high prevalence of dementia in older adults hospitalised with COVID-19. 2 It is so far unclear whether there is any direct effect of dementia pathologies as dementia is a disease of old age, and thus likely to be associated with a variety of comorbidities, in particular, frailty, which may further exacerbate the risk of severe infection. In addition up to one third of COVID patients have demonstrated neurological sequelae 3 and there may be both direct (viral infection within the brain, vascular effects) and indirect effects (eg, host immunological response, impact of treatment) of SARS-CoV-2 on the brain. 4 It is therefore possible that SARS-CoV-2 infection may accentuate any pre-existing neurodegenerative disease.

Dementia with Lewy bodies (DLB) represents at least 4.2% of community-based dementia, and 7.5% of cases in clinical dementia populations. 5 Under-diagnosis is however common, meaning the true figure is likely to be higher. 6 This form of dementia presents with several distinct cognitive, neuropsychiatric, sleep, autonomic and motor symptoms. These include spontaneous alterations in concentration and attention, recurrent well-formed visual hallucinations, and rapid eye movement (REM) sleep behaviour disorder. Further problems relate to severe autonomic dysfunction (eg, severe constipation, orthostatic hypotension, and urinary difficulties), and spontaneous features of Parkinsonism, including gait impairment. 7 People with DLB are admitted to hospital more frequently, and utilize inpatient care to a substantially higher degree, than people with Alzheimer's disease (AD) or the general elderly population. 8 They also have higher and earlier mortality than people with other dementias. 9, 10 The myriad of symptoms associated with DLB results in a complex condition with significant functional disability and a likely vulnerability to COVID-19. Furthermore, DLB patients may be biased against in treatment decision algorithms that consider multimorbidity, particularly for critical care access. For example within the UK, the current NICE guidance on critical care for COVID-19 algorithm (https://www.nice.org.uk/guidance/NG159) uses the Clinical Frailty Scale, whereby a higher category of frailty reduces the likelihood of receiving critical care. On a measure of this type, it is probable that people with DLB would score highly as a consequence of both their physical and their cognitive problems.

As the current wave of COVID-19 recedes and jurisdictions move to staged social distancing, people with DLB may need to remain shielded longer than some other groups due to their susceptibility and age profile. Even where a person with DLB avoids developing COVID-19 and hospitalisation, adverse outcomes may result from this period of enforced social isolation. People with DLB invariably have their healthcare needs managed by professionals from a wide variety of specialties, including doctors (primary care, psychiatrists, neurologists, geriatricians), nurses, psychologists, occupational therapists, pharmacists, carers, social workers and physiotherapists, in addition to benefiting from the support of charities and community groups. This raises a particular challenge as shielding or social isolation risks at least some healthcare and psychosocial needs remaining unmet.

One feature of DLB is an increased risk of infection, notably bronchopneumonia. 11 This is particularly concerning during the current pandemic, where it might exacerbate, or be mistaken for COVID-19 symptoms. Secondary pneumonias may be more common given that people with DLB often have a pharyngeal-type dysfunction, which results in a high prevalence of silent aspiration. 12 This could contribute to diagnostic difficulty especially in conjunction with anosmia, another symptom commonly associated with DLB, 13 and which is also indicative of COVID-19.

In common with other dementias, a person with DLB may fail to notice or report symptoms, of, for example, fever, which may indicate COVID-19 or another infection. Furthermore, coupled with a reduction in the availability of face-to-face healthcare provision, infections may progress significantly before detection. Family caregivers are important partners in detecting changes in normal behaviour, which may indicate a developing illness. However, they may need guidance in asking appropriate questions particularly where they are living apart and maintaining contact by phone.

In the UK 'Telemedicine' is replacing many face-to face consultations during the current pandemic and is being viewed as a potential longer-term alternative for primary care. 14 In addition to age related hearing/visual impairment, people with DLB may find this form of communication particularly challenging to navigate especially when they are feeling unwell. They have significantly more visual complaints when compared to people with AD, including misjudging objects, difficulty reading, and increased double vision 15 and thus could struggle to interact with the virtual medium. Language dysfunction is more severe in DLB than other dementias and includes impairments of speech fluency, speech freezing, reduced pitch range and hypophonia. 16, 17 This may lead to problems in both responding to on-screen questions and being understood. Such challenges need consideration when transforming services to ensure equality of access.

People with DLB are at increased risk of developing delirium if they develop an infection compared with AD. 18 As infection progresses in severity, treatment becomes more difficult and the risk of delirium and hospitalisation increases. The maintenance of good general hygiene is therefore important to reinforce, for example, where there are continence difficulties, as urinary tract infections can escalate quickly. It is also vital that family caregivers understand the importance of the early assessment of suspected infections by a health care professional. This could include reassurance that perceived pressures on healthcare staff and concerns about overburdening services do not warrant any delay in seeking help. It is important that caregivers inform health care professionals of the DLB diagnosis in any communication. This will highlight to them the need for caution when prescribing anti-psychotic medication due to the risk of a severe sensitivity syndrome. 19 Families can assist healthcare professionals to differentiate between fluctuations commonly experienced by their family member and unfamiliar behaviour that may indicate delirium. Other physical symptoms of concern include orthostatic hypotension. This is more common in DLB than other dementias with a greater reduction in systolic blood pressure and a more prolonged period of orthostasis. 20 This may increase the risk of falls, which is also higher for people with DLB than for other dementias. 21 This possibility is exacerbated by poor hydration, a potential concern if people are missing the usual prompts from family caregivers. Good hydration can be maintained through reminders by phone, sharing drinks virtually during video calls or alarms set at regular intervals. If there is a risk of falls going undetected, families may need guidance to assess the relative risks of visiting rather than remaining physically distant. • Adverse effects may also occur from social isolation, the under-treatment of existing DLB related symptoms/problems and the negative impact on caregivers.

• A vigilant multi-disciplinary approach is needed to meet the health and psychosocial needs of people with DLB and support family caregivers. the UPDRS. 22 While the exercise capacity of people with DLB is relatively low in comparison with other cohorts with dementia, any reduction may heighten the falls risk. Maintaining safe home-based activities, for example, by following appropriate on-line fitness programmes, in many cases with assistance, may reduce the impact of the lost exercise opportunities and minimise skeletal or muscular pain from reduced mobility.

A lack of meaningful activity adversely affects quality of life in people with dementia, 23 and people with DLB benefit from cognitively stimulating activities. 24 Non-pharmacological treatment modalities are recommended to manage behavioural disturbance in people with dementia. 25, 26 This is particularly salient given that delivering face-to-face or group nonpharmacological interventions to reduce agitation, for example, music therapy or sensory stimulation, 27 may be impossible due to the difficulties in maintaining social distancing. Any resurgence or development of behavioural difficulties may therefore require pharmacological interventions, and caregivers should be alert to the need to discuss concerns and treatment options with health care professionals.

Depression or low mood are common features of DLB 28 with depression more frequent than in AD. 29 Depressive symptoms also differ between DLB and AD with apathy and pervasive anhedonia significantly higher in people with DLB. 30 Apathy often responds to stimulation from social activities and in the absence of these, is important to find alternatives, for example assisting with household tasks, baking or straightforward games. Family caregivers can be encouraged to offer managed choices to reduce any perceived loss of control over how the day is spent. If the person with DLB lives alone and seems disinclined to initiate available activities such as jigsaws, crafts or gardening, caregivers can be encouraged to prompt, enthuse and encourage via any accessible communication routes. Resources to enhance activities can be ordered online and depending on the level of impairment, turn-taking activities may be possible via video calls to maintain engagement. Family caregivers should be advised to contact a health care professional if they detect a deterioration in mood as changes to medication may be warranted.

Reduced social stimulation, a lack of daytime routine, and less physical activity may exacerbate excessive daytime somnolence, a common feature of DLB, 31 

Supporting someone with DLB poses a substantial burden on family caregivers. Compared with AD, caregiver burden in family caregivers of people with DLB is rated 30% higher on the Relative Stress Scale 35 and a major depressive disorder in the caregiver is significantly more likely. 36 The COVID-19 pandemic is likely to create multiple further difficulties.

Physical outcomes may include caregiver fatigue from the increased hours spent supporting the person with DLB with the everyday activities of living, particularly in spousal caregivers who may have age related physical limitations. Additional personal care needs may arise where formal caregivers are unable to visit and routine appointments such as podiatry are unavailable. Many families rely on respite from daycentres or short-term care home admission to reduce caregiving hours and care demands to a manageable level. The closure of these removes the opportunity for caregivers to 'recharge'

and requires them to be constantly available. This may be particularly difficult where there is no foreseeable end in sight.

Mental health challenges for caregivers include managing their own anxiety and coping with uncertainty, including over the duration of isolation, whilst containing anxiety in their care-recipient. Finding ways to accommodate changes to dietary preferences in the face of shortages in essential food items may be stressful. Difficulty obtaining regular prescriptions and appointments such as physiotherapy to maintain mobility may also be concerning for caregivers who are likely to be aware of the detrimental effects of being without these. Feelings of anticipatory grief related to a DLB diagnosis contribute to caregiver burden 37 Suggestions to caregivers may include trying to concentrate on those things they can control, that is, making a contingency plan for if they get ill, keeping up good nutrition, and maintaining a daily routine rather than focussing on situations that they cannot control. This may include limiting the time spent watching news updates. They may be encouraged to consider how they have coped with previous challenging situations and whether they can adopt similar techniques again.

Practical solutions to pressing problems such as arranging volunteer shoppers and medication deliveries may be as important as offering psychological support.

Detrimental effects for caregivers may also be reduced through maintaining contact with their informal social networks, bearing in mind that where platforms such as video calls are unfamiliar, additional support may be needed. Carers' organisations and faith groups may be beneficial as may opportunities to 'buddy' other caregivers and so offer as well as receive support. Accessing DLB specific advice and information from charities such as the Lewy Body Dementia Association (https://lbda.org) and the Lewy Body Society (https:// lewybody.org) can also be encouraged.

During the urgent restructuring in response to COVID-19, specialist services in hospital-based clinics were suspended, and many people with DLB only had access to primary care. Although some services were subsequently reinstated as telephone or video consultations, this highlights an important concern about how primary care teams can access specialist advice and feel equipped to provide proxy specialist care when the need arises. Establishing links between health care professionals in these areas is vital to enable case discussions and requests for urgent reviews to take place, and to facilitate sharing of 

Pre-existing comorbidities predicting severe COVID-19 in older adults in the UKbiobank community cohort. medRxiv

International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC)

Neurological complications of coronavirus and COVID-19

Neurological implications of COVID-19 infections

The prevalence and incidence of dementia with lewy bodies: a systematic review of population and clinical studies

Clinical prevalence of lewy body dementia

The clinical characteristics of dementia with lewy bodies and a consideration of prodromal diagnosis

Hospitalization in people with dementia with lewy bodies: frequency, duration, and cost implications

Mortality in dementia with lewy bodies compared with Alzheimer's dementia: a retrospective naturalistic cohort study

Survival time and differences between dementia with lewy bodies and Alzheimer's disease following diagnosis: a meta-analysis of longitudinal studies

Differences in clinical course between dementia with lewy bodies and Alzheimer's disease

Dysphagia in lewy body dementia-a clinical observational study of swallowing function by videofluoroscopic examination

Severe hyposmia distinguishes neuropathologically confirmed dementia with lewy bodies from Alzheimer's disease dementia

Doctors question Hancock's idea of GP video consultations for all

The influence of two common dementia types on visual symptoms

Freezing of speech single questionnaire as a screening tool for cognitive dysfunction in patients with dementia with lewy bodies

Impairments of speech fluency in Lewy body spectrum disorder

Research criteria for the diagnosis of prodromal dementia with lewy bodies

Lewy body dementias

The period of hypotension following orthostatic challenge is prolonged in dementia with lewy bodies

Fall risk and fracture. Falls in patients with dementia

Exercise for individuals with lewy body dementia: a systematic review

Doing as much as I can do: the meaning of activity for people with dementia

Parkinson's-adapted cognitive stimulation therapy: feasibility and acceptability in lewy body spectrum disorders

Non-pharmacological interventions for lewy body dementia: a systematic review

The use of antipsychotic medication for people with dementia: Time for action

Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials

Dementia with lewy bodies is associated with higher scores on the geriatric depression scale than is Alzheimer's disease

Psychiatric morbidity in dementia with lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease

Depression in dementia with lewy bodies: a comparison with Alzheimer's disease

Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with lewy bodies and Alzheimer's disease

Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management

Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations

New evidence on the management of lewy body dementia

Caregiver burden in family carers of people with dementia with lewy bodies and Alzheimer's disease

Depression in the carers of dementia sufferers: a comparison of the carers of patients suffering from dementia with lewy bodies and the carers of patients with Alzheimer's disease

Self-efficacy and social support for psychological well-being of family caregivers of care recipients with dementia with lewy bodies, Parkinson's disease dementia, or Alzheimer's disease

Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: the DIA-MOND Lewy study

Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium

Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND lewy study

The authors have no conflict of interest to declare.

https://orcid.org/0000-0002-2020-5981Alan J. Thomas https://orcid.org/0000-0002-6667-9533